News|Videos|October 23, 2023

Prostate Cancer Imaging: PSMA Agents and Radiotracer Options

Author(s)David Albala, MD

Insight into advancements in prostate cancer imaging using PSMA agents like gallium and F-18, their unique characteristics, and the considerations in choosing the right radiotracer for accurate detection.

Episodes in this series

Expert on prostate cancer

EP. 1 An Overview of PSMA-PET Scans and Prostate Cancer Imaging

Expert on prostate cancer

EP. 2 Advancements in Prostate Cancer Imaging: The Evolution of PET Scans

Expert on prostate cancer

EP. 3 Prostate Cancer Imaging: PSMA Agents and Radiotracer Options

Expert on prostate cancer

EP. 4 Challenges and Progress in Advanced Imaging for Prostate Cancer

Expert on prostate cancer

EP. 5 CMS Reimbursement Shift in Prostate Cancer: Streamlining Radiotracer Payments

Expert on prostate cancer

EP. 6 Prostate Cancer Imaging and Care in 2023: Best Practices

Expert on prostate cancer

EP. 7 Practical Guidance for Prostate Cancer Imaging: PSMA-PET Scans and Patient Selection

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD

ByMartin Schoen, MD, PhD,Hannah Clarke

September 7th 2026

Higher saturated fat intake associated with increased mortality in nonmetastatic prostate cancer

ByHannah Clarke

September 7th 2026

Why methodology matters in real-world evidence studies

ByMartin Schoen, MD, PhD

September 3rd 2026

Prostate Cancer Awareness Month: Prostate cancer screening in 2026

ByShiv B. Patel, MD,Hannah Clarke

September 3rd 2026

Enrollment goal met in phase 3 study of 68Ga-PSMA-PET in pre-biopsy setting

ByHannah Clarke

September 2nd 2026

Latest CME

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

AI-generated profiles impersonate female urologists to market ED products online

Higher saturated fat intake associated with increased mortality in nonmetastatic prostate cancer

Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD

FDA reports increased demand, supply efforts for estradiol transdermal patches

What the Efficacy Data from KEYNOTE-B15/EV-304 Revealed